Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis

This review discusses the most recent evidence for currently available risk stratification tools in the detection of clinically significant prostate cancer (csPCa), and evaluates diagnostic strategies that combine these tools. Novel blood biomarkers, such as the Prostate Health Index (PHI) and 4Ksco...

Descripción completa

Detalles Bibliográficos
Autores principales: Osses, Daniël F., Roobol, Monique J., Schoots, Ivo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480079/
https://www.ncbi.nlm.nih.gov/pubmed/30986955
http://dx.doi.org/10.3390/ijms20071637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480079/
https://www.ncbi.nlm.nih.gov/pubmed/30986955
http://dx.doi.org/10.3390/ijms20071637

Ejemplares similares